Diversify Advisory Services LLC Purchases 496 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Diversify Advisory Services LLC raised its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 2.5% during the fourth quarter, according to its most recent ...
The American Journal of Managed Care13h
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction, linked to ...
devdiscourse14h
Global Health News: Abroad and in Focus
Recent news highlights include Hong Kong shareholders rejecting Fosun's buyout of Henlius Biotech, Abbott focusing on glucose monitors amidst currency woes, FDA warning on multiple sclerosis drugs, ...
Managed Healthcare Executive15h
FDA Adds Boxed Warning to MS Drug Copaxone
Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...
JD Supra17h
Precedential Federal Circuit Decision Overturns Lack of Written Description Based on Later-Discovered Technology
On January 10, 2025, the US Court of Appeals for the Federal Circuit issued a precedential opinion in Novartis Pharmaceuticals Corp. v. Torrent ...
The Pharma Letter18h
FDA warns of rare but serious allergic reaction with glatiramer
The US Food and Drug Administration (FDA) is warning about the risk of a rare but serious allergic reaction with the medicine ...
FDA adds boxed warning to Teva’s Copaxone for allergic reaction
The Food and Drug Administration is adding a boxed warning about the risk of an allergic reaction for Teva‘s (TEVA) Copaxone and Sandoz’s ...
Future Market Insights21h
Small-Molecule Injectable Industry to Reach USD 131.7 Billion by 2033, Growing at a 7.3% CAGR
The global small-molecule injectable market is projected to grow at a 7.3% CAGR, reaching USD 131.70 billion by 2033. Rising ...
Women's Health Market Set To Grow 4.8% Annually Through 2033
Women's Health Market size is expected to reach US$ 66 Billion by 2033, from US$ 41.3 Billion in 2023, growing at a CAGR of 4.8%. Lawrence John Prudour +91 91308 55334 ...
Drug Store News1d
Teva partners with Klinge Biospharma, Formycon for Eylea biosimilar candidate in Europe, Israel
Teva Pharmaceuticals International GmbH, a subsidiary of Teva, has entered into a strategic collaboration with Klinge Biopharma GmbH and Formycon AG for the semi-exclusive commercialization of FYB203, ...
JD Supra1d
Federal Circuit Says Proper Orange Book-Listed Patent Must Claim Active Ingredient
In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon ...
Cystic Fibrosis Therapeutics Market Booming Worldwide With Analysis, Growth, Upcoming Trend & Future Scope By 2033
The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...